Malignant glioma – Basic Information

Go back

Malignant glioma represents one of the most challenging diagnoses in brain cancer, affecting thousands of people each year with aggressive tumors that grow rapidly and invade healthy brain tissue. Understanding this complex disease, its causes, symptoms, and treatment options is essential for patients, families, and anyone seeking to learn about brain health.

Understanding Malignant Glioma

Malignant glioma is a type of brain tumor that develops from glial cells, which are the supporting cells that surround and protect nerve cells in the brain and spinal cord. These cells normally have essential roles in maintaining brain function, but when they grow out of control, they form tumors that can be life-threatening.[1]

The term “malignant” means these tumors are cancerous and aggressive. Unlike some brain tumors that grow slowly and stay in one place, malignant gliomas grow rapidly and spread into surrounding healthy brain tissue. They are considered high-grade tumors, which refers to how quickly they grow and how abnormal the cells look under a microscope.[2]

Malignant gliomas include several specific types of brain tumors. These include anaplastic oligodendroglioma, anaplastic astrocytoma, and glioblastoma, which is the most aggressive form and is classified as grade IV by the World Health Organization. Glioblastomas account for approximately 60 to 70 percent of all malignant gliomas, while anaplastic astrocytomas represent 10 to 15 percent, and anaplastic oligodendrogliomas make up about 10 percent of cases.[3]

These tumors are considered among the deadliest of human cancers. In its most aggressive form, glioblastoma, the median survival time ranges from 9 to 12 months despite maximum treatment efforts. This statistic has changed little over several decades, despite technological advances in surgery, radiation therapy, and clinical trials of various treatments.[5]

How Common Are Malignant Gliomas

The incidence of malignant gliomas is approximately 5 cases per 100,000 people. These tumors make up 35 to 45 percent of all primary brain tumors, making them a significant health concern worldwide.[3]

The occurrence of these tumors has increased slightly over the past two decades, especially among elderly people. The peak incidence occurs in the fifth and sixth decades of life. For glioblastoma specifically, the median age at diagnosis is 64 years, while for anaplastic gliomas it is 45 years.[3]

Malignant gliomas affect men more frequently than women. They are approximately 40 percent more common in men than in women. There are also differences based on race, with these tumors occurring twice as frequently in white populations compared to black populations.[3]

In Slovenia, data collected from 1991 to 2005 showed that a total of 1,636 patients were diagnosed with brain cancer during this period. Among cases where microscopic verification was performed, 82 percent were gliomas. Of these gliomas, two-thirds were glioblastoma, 14 percent were astrocytoma, and 10 percent were oligodendroglioma. Approximately 60 percent of patients were diagnosed between the ages of 50 and 74 years, and 25 percent were diagnosed between ages 20 and 49 years.[3]

Gliomas are most common in adults after age 65 and in children before age 12, though the disease can affect people at any age. Many adults with lower-grade gliomas that later become malignant are diagnosed at relatively young ages, often in their 20s, 30s, and 40s.[2]

What Causes Malignant Gliomas

Malignant gliomas develop when genetic changes occur in glial cells, causing them to grow uncontrollably. However, doctors don’t always understand why these genetic changes happen in the first place.[2]

The only firmly established environmental risk factor identified for the majority of malignant gliomas is exposure to ionizing radiation. This type of radiation, which includes medical radiation used in treatments or imaging, has been clearly linked to increased risk of developing these brain tumors.[3]

There is suggestive evidence, though with unclear importance, that immunologic factors may play a role in the development of malignant gliomas. Research has shown that patients with atopy, a genetic tendency to develop allergic diseases, have a reduced risk of gliomas. Additionally, patients with glioblastoma who have elevated levels of IgE, a type of antibody involved in allergic reactions, appear to live longer than those with normal levels.[3]

Gene variations that affect how the body handles toxins, repairs DNA damage, and regulates cell growth cycles have also been implicated in the development of gliomas. These genetic factors suggest that some people may have a biological predisposition to developing these tumors when exposed to certain environmental triggers.[3]

⚠️ Important
Most malignant gliomas are not linked to clear risk factors that people can control. The disease is not contagious and cannot be spread from person to person. While exposure to ionizing radiation is a known risk factor, most people who develop malignant gliomas have no identifiable cause for their disease.

Risk Factors for Developing Malignant Gliomas

Anyone can develop a malignant glioma, but certain factors may increase a person’s risk. Understanding these risk factors can help people be aware of their potential vulnerability to the disease, though it’s important to remember that having a risk factor doesn’t mean someone will definitely develop a brain tumor.[2]

Age is one of the most significant risk factors. Gliomas are most common in adults after age 65, though they can also occur in children before age 12. The risk varies depending on the specific type of glioma, with glioblastoma being more common in older adults.[2]

Family history plays a role in some cases. Some genetic disorders that a person can inherit from their biological family may increase the risk of developing gliomas. A few genetic syndromes are associated with increased risk for malignant gliomas. If brain or spinal cord tumors run in a family, genetic testing for cancer risk may be something to consider after discussing it with a healthcare provider.[3]

Race appears to influence risk, with people who are white being more likely to develop gliomas compared to other races. This difference is seen across multiple studies and populations.[2]

Repeated exposure to radiation or certain chemicals may increase risk. This includes medical radiation exposure from previous treatments or diagnostic procedures, as well as occupational exposure to specific toxic substances. However, the exact relationship between chemical exposure and glioma risk is still being studied.[2]

Signs and Symptoms of Malignant Gliomas

The symptoms of malignant glioma depend on where the tumor is located in the brain and how large it has grown. Because different parts of the brain control different functions, a tumor in one area will cause different symptoms than a tumor in another area. Symptoms may also vary depending on the type of glioma, its size, and how quickly it is growing.[1]

Headaches are one of the most common symptoms of malignant glioma. These headaches are often particularly painful in the morning and may worsen with physical activity. The headaches occur because the tumor increases pressure inside the skull as it grows.[1]

Nausea and vomiting are frequent symptoms, especially in the morning. These symptoms are also related to increased pressure inside the skull. The nausea may be severe and persistent, affecting a person’s ability to eat and maintain proper nutrition.[1]

Changes in mental function are common and can be very concerning for patients and families. These may include confusion, problems with thinking and understanding information, memory loss, personality changes, or increased irritability. A person may seem different from how they usually act, which can be distressing for loved ones to witness.[1]

Vision problems occur frequently with brain tumors. These can include blurred vision, double vision, or loss of peripheral vision. Some people experience sudden vision loss. These symptoms happen when the tumor affects the parts of the brain that control vision or when it puts pressure on the optic nerves.[1]

Seizures are another important symptom of malignant gliomas. For some people, a seizure may be the first sign that something is wrong. Seizures can take many forms, from brief staring spells to full convulsions with loss of consciousness.[2]

Difficulty walking or keeping balance is common, along with general dizziness. People may feel unsteady on their feet or have coordination problems that make everyday activities challenging.[2]

Weakness or numbness on one side of the body, called hemiparesis, can occur when the tumor affects the parts of the brain that control movement and sensation. This can make it difficult to use an arm or leg on one side of the body.[2]

Trouble speaking or communicating, known as aphasia, may develop if the tumor affects language centers in the brain. A person may have difficulty finding words, speaking clearly, or understanding what others are saying.[2]

New depression or anxiety, sudden mood swings, and personality changes can all be symptoms of a brain tumor. These emotional and behavioral changes occur because the tumor affects brain regions involved in mood regulation and personality.[2]

Prevention and Early Detection

Unfortunately, there are no proven ways to prevent malignant gliomas because the causes of most cases are unknown. Unlike some other cancers where lifestyle changes can reduce risk, malignant gliomas don’t have clear preventable risk factors that people can avoid.[2]

The only established environmental risk factor is exposure to ionizing radiation. People can limit unnecessary radiation exposure by avoiding medical imaging procedures with radiation when they’re not medically necessary. However, when doctors recommend imaging procedures for medical reasons, the benefits typically outweigh the small risk from radiation exposure.[3]

Staying informed about symptoms and seeking medical care early if concerning signs develop may improve outcomes. While this isn’t prevention in the traditional sense, early detection can sometimes lead to treatment at an earlier stage of the disease.[2]

For people with a family history of brain tumors or genetic syndromes associated with increased cancer risk, genetic counseling may be helpful. This can help individuals understand their personal risk and make informed decisions about monitoring and medical care. However, routine screening for brain tumors in people without symptoms is not recommended because malignant gliomas are relatively rare and screening tests have limitations.[2]

How Malignant Gliomas Affect the Brain and Body

Understanding what happens in the body when a malignant glioma develops helps explain why these tumors are so serious and difficult to treat. The disease causes multiple changes in normal brain structure and function that lead to the symptoms patients experience.[1]

Malignant gliomas begin when glial cells undergo genetic changes that cause them to grow and divide uncontrollably. As these abnormal cells multiply, they form a mass or tumor. The tumor grows by both increasing in size at its center and by sending out extensions or “fingers” that invade surrounding healthy brain tissue. This invasive growth pattern is one reason why malignant gliomas are so difficult to treat completely.[1]

As the tumor grows, it takes up space inside the rigid skull. Because the skull cannot expand, the growing tumor increases pressure inside the head, a condition called increased intracranial pressure. This pressure causes many of the common symptoms like headaches, nausea, and vomiting. The pressure can also affect brain function more generally, leading to confusion and changes in consciousness.[1]

The tumor can directly damage or destroy healthy brain tissue in the area where it grows. Different parts of the brain control different functions, so the specific effects depend on the tumor’s location. A tumor in the frontal lobe might cause personality changes and difficulty with planning and decision-making. A tumor in the motor cortex could cause weakness or paralysis. A tumor near language centers might cause difficulty speaking or understanding speech.[1]

Malignant gliomas can disrupt the normal electrical activity of the brain, leading to seizures. The tumor tissue itself is irritating to surrounding brain cells, and this irritation can trigger abnormal electrical discharges that spread through the brain, causing a seizure.[2]

The tumor also affects blood flow in the brain. Glioblastomas in particular contain areas of abnormal blood vessel growth, a process called angiogenesis. These blood vessels are poorly formed and leaky, which can lead to swelling around the tumor. The tumor may also contain areas where tissue has died, called necrosis, because the blood supply cannot keep up with the tumor’s rapid growth.[7]

Unlike many other cancers that spread to distant parts of the body through the bloodstream or lymphatic system, malignant gliomas rarely spread outside the brain and spinal cord. However, they can spread to other areas within the brain itself. They may grow across to the opposite side of the brain through connecting fibers called the corpus callosum or spread through the fluid-filled spaces in the brain called ventricles.[7]

The treatments used for malignant gliomas, including surgery, radiation, and chemotherapy, can also affect brain function. These treatments may cause cognitive changes such as difficulty concentrating, learning, and remembering new information. While these effects are often necessary trade-offs for treating the tumor, they can significantly impact a patient’s quality of life.[20]

Ongoing Clinical Trials on Malignant glioma

  • Study Comparing Lomustine Alone and Lomustine with Bevacizumab for Patients with Recurrent Glioblastoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany The Netherlands
  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study of ONC201 for Patients with Newly Diagnosed H3 K27M-mutant Diffuse Glioma After Radiotherapy

    Recruiting

    1 1
    Investigated diseases:
    Austria Denmark Germany Italy The Netherlands Spain
  • Study on ONC201 and Paxalisib for Children and Young Adults with Diffuse Midline Gliomas, Including Diffuse Intrinsic Pontine Gliomas

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety of Photodynamic Therapy with Aminolevulinic Acid Hydrochloride for Patients Aged 18-75 with Grade IV Glioblastoma

    Not recruiting

    1 1
    Investigated diseases:
    France
  • Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland France +10

References

https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc-20350251

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://pmc.ncbi.nlm.nih.gov/articles/PMC4852970/

https://www.nicklauschildrens.org/conditions/malignant-glioma

https://genesdev.cshlp.org/content/15/11/1311

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/glioma-adults

https://www.abta.org/tumor_types/glioblastoma-gbm/

https://braintumourresearch.org/pages/types-of-brain-tumours-glioma?srsltid=AfmBOorqvuFIYlcORI8ixjO6FPW56jXFfxSQz2EKaj5F_3teQQKl9hDO

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://pmc.ncbi.nlm.nih.gov/articles/PMC4852970/

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.mskcc.org/cancer-care/types/glioma/glioma-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC1304839/

https://www.brighamandwomens.org/neurosurgery/videos/advancing-malignant-gliomas-treatment-video-transcript

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/glioblastoma

https://www.aaroncohen-gadol.com/en/patients/glioma/survival/end-of-life

https://braintumor.org/news/lets-talk-about-glioblastoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8146925/

https://my.clevelandclinic.org/health/diseases/21969-glioma

https://www.cancer.gov/news-events/cancer-currents-blog/2023/low-grade-glioma-optimum

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://www.abta.org/tumor_types/glioblastoma-gbm/

https://glioblastomafoundation.org/news/malignant-brain-tumor

https://www.thebraintumourcharity.org/living-with-a-brain-tumour/relationships/supporting-friends-and-family/support-family-and-friends/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Can malignant gliomas be cured?

Malignant gliomas are very difficult to cure completely because they invade surrounding brain tissue in a way that makes total removal impossible. Treatment focuses on controlling the disease and managing symptoms. Some types of gliomas, particularly glioblastoma, have remained among the most challenging cancers to treat despite decades of research.

What is the difference between low-grade and high-grade gliomas?

Low-grade gliomas (grades 1 and 2) grow slowly and the cells look more similar to normal brain cells. High-grade gliomas (grades 3 and 4) grow rapidly and the cells look very abnormal. Grade 4 gliomas, such as glioblastoma, are the most aggressive and fastest growing. Early detection and treatment of low-grade gliomas may slow or prevent them from becoming high-grade.

Are malignant gliomas hereditary?

Most malignant gliomas are not inherited. However, some genetic disorders that run in families can increase the risk of developing brain tumors. A few genetic syndromes are associated with increased risk for malignant gliomas. If brain or spinal cord tumors run in your biological family, you may want to consider genetic testing and counseling.

Why do malignant gliomas cause headaches?

Malignant gliomas cause headaches primarily by increasing pressure inside the skull. As the tumor grows, it takes up space in the rigid skull, which cannot expand. This increased intracranial pressure causes headaches that are often worse in the morning and may worsen with physical activity. The headaches can be accompanied by nausea and vomiting.

What age groups are most affected by malignant gliomas?

The peak incidence of malignant gliomas occurs in the fifth and sixth decades of life (ages 40-60). Glioblastoma specifically has a median diagnosis age of 64 years. However, malignant gliomas can affect people at any age. Gliomas are also relatively common in children before age 12, though the types that affect children often differ from those in adults.

🎯 Key takeaways

  • Malignant gliomas are aggressive brain cancers that grow rapidly and invade healthy brain tissue, making them among the deadliest human cancers.
  • These tumors affect approximately 5 in 100,000 people and are 40 percent more common in men than women.
  • The only clearly established environmental risk factor is exposure to ionizing radiation, while most cases have no identifiable cause.
  • Symptoms vary widely depending on tumor location but commonly include morning headaches, nausea, confusion, vision changes, and seizures.
  • Unlike most cancers, malignant gliomas rarely spread outside the brain and spinal cord, though they can invade different areas within the brain.
  • Glioblastoma accounts for 60 to 70 percent of malignant gliomas and has a median survival of 9 to 12 months despite aggressive treatment.
  • There are no proven prevention strategies for malignant gliomas, making early recognition of symptoms important for prompt medical attention.
  • Modern classification of gliomas now uses molecular markers and genetic testing, not just cell appearance, to categorize tumors and guide treatment.